Table 1. Comparison of baseline and laboratory characteristics among the groups.
Variables | Control (n = 52) | Normal geometry (n = 99) | Concentric remodeling (n = 80) | Eccentric hypertrophy (n = 69) | Concentric hypertrophy (n = 95) | p value |
Baseline findings | ||||||
Age, years | 51.8 ± 4.6 | 52.4 ± 4.3 | 50.8 ± 4.9 | 52.1 ± 3.8 | 51.1 ± 7.8 | 0.286 |
Gender, male | 26 (50%) | 48 (48.5%) | 37 (46.3%) | 29 (42.0%) | 44 (46.3%) | 0.506 |
BMI, kg/m2 | 26.6 ± 1.1* | 27.4 ± 2.7* | 30.4 ± 4.7† | 29.0 ± 2.4 | 29.4 ± 4.2 | < 0.001 |
SBP, mmHg | 116.2 ± 7.8‡ | 150.8 ± 17.9§ | 158.0 ± 20.3** | 153.3 ± 18.1** | 166.6 ± 17.4 | < 0.001 |
DBP, mmHg | 71.3 ± 7.1‡ | 95.4 ± 12.6* | 102.5 ± 11.2** | 99.8 ± 14.6** | 110.0 ± 13.4 | < 0.001 |
Heart Rate, b/m | 75.9 ± 8.6 | 78.9 ± 12.1 | 79.0 ± 8.3 | 76.3 ± 10.2 | 77.2 ± 9.6 | 0.231 |
Smoking, n (%) | 20 (38.5%) | 29 (29.3%) | 23 (28.8%) | 29 (42.0%) | 32 (33.7%) | 0.353 |
Laboratory | ||||||
Glucose, mg/dl | 89.1 ± 8.2 | 88.4 ± 8.4 | 90.3 ± 9.1 | 89.5 ± 3.4 | 90.7 ± 9.6 | 0.347 |
TC, mg/dl | 169.2 ± 23.2‡ | 179.6 ± 23.7§ | 191.3 ± 23.1 | 187.6 ± 22.9 | 193.0 ± 37.4 | < 0.001 |
Triglyceride, mg/dl | 141.8 ± 21.8† | 151.3 ± 30.3† | 152.5 ± 27.3† | 163.8 ± 40.4** | 176.9 ± 41.7 | < 0.001 |
HDL, mg/dl | 40.4 ± 4.5## | 42.5 ± 5.6†† | 38.9 ± 4.9** | 40.0 ± 6.3 | 41.4 ± 7.1 | 0.001 |
LDL, mg/dl | 100.5 ± 24.7# | 106.8 ± 23.0# | 121.9 ± 20.0 | 114.8 ± 21.1 | 116.1 ± 32.5 | < 0.001 |
Hs-CRP, mg/dl | 0.65 ± 0.20 | 0.67 ± 0.21 | 0.73 ± 0.26 | 0.77 ± 0.23‡‡ | 0.93 ± 0.28§§ | < 0.001 |
Creatinine, mg/dl | 0.74 ± 0.19† | 0.73 ± 0.14† | 0.88 ± 0.15** | 0.78 ± 0.14† | 0.92 ± 0.18 | < 0.001 |
Uric acid, mg/dl | 3.8 ± 0.7‡ | 4.5 ± 0.9 | 4.4 ± 1.0 | 4.5 ± 0.8 | 4.4 ± 0.9 | < 0.001 |
BMI, body mass index; CH, concentric hypertrophy; CR, concentric remodeling; DBP, diastolic blood pressure; EH, eccentric hypertrophy; HDL, high density lipoprotein; Hs-CRP, high sensitive C reactive protein; LDL, low density lipoprotein; NG, normal geometry; SBP, systolic blood pressure; TC, total cholesterol.
* p < 0.05 vs. CR, EH and CH groups; # p < 0.05 vs. CR, CH and EH groups; † p < 0.05 vs. EH and CH groups; ‡ p < 0.05 vs. NG, CR, EH and CH groups; § p = 0.05 vs. CR and CH groups; ** p < 0.05 vs. CH group; ## p < 0.05 vs. NG group; †† p < 0.05 vs. CR and EH groups; ‡‡ p < 0.05 vs. control and NG groups; §§ p < 0.05 vs. control, NG, CR and EH groups.